AbbVie - Largest Companies by Marketcap, Revenue, Net Income and Employees
Top Corporates Hub
AbbVie
ABBV
|
NYSE
|
United States
33
-2
Rank
$295.34B
Market Cap
$56.33B
+$ 0.8B
+1.44%
Revenue
$3.71B
-$ 1.37B
-26.97%
Earnings
55K
+5K
+10%
Employees
About
AbbVie Inc. (ABBV)
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.
- Sector: Health Technology
- Industry: Pharmaceuticals: Major
- Headquarters:
Latest News
-
AbbVie (ABBV) Stock Weighs DCF Upside Against Elevated P/E At US$227.73
13.06.2026 -
3 Stocks That Might Be Up To 39.8% Below Their Estimated Intrinsic Value
12.06.2026 -
AbbVie Presents New Data at EHA 2026 Congress for VENCLEXTA®/VENCLYXTO® (venetoclax) in First-Line Chronic Lymphocytic Leukemia Highlighting Long-Term Treatment Outcomes for Patients: Nine-Year Results
12.06.2026 -
Coastal Financial And 2 Additional Stocks Estimated To Be Priced Below Intrinsic Value
10.06.2026 -
Final Trades: AbbVie, Devon Energy and the 2-Year and 10-Year Treasuries
10.06.2026